These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 1636249

  • 21. Application of megakaryocytic morphology in diagnosing 5q- syndrome.
    Thiede T, Engquist L, Billström R.
    Eur J Haematol; 1988 Nov; 41(5):434-7. PubMed ID: 3208866
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Diagnostic criteria for hypocellular acute leukemia: a clinical entity distinct from overt acute leukemia and myelodysplastic syndrome.
    Nagai K, Kohno T, Chen YX, Tsushima H, Mori H, Nakamura H, Jinnai I, Matsuo T, Kuriyama K, Tomonaga M, Bennett JM.
    Leuk Res; 1996 Jul; 20(7):563-74. PubMed ID: 8795690
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Clinical aspects of the myelodysplastic syndromes (MDS) with special reference to refractory anemia with excess of blasts (RAEB).
    Omine M, Yamauchi H.
    Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):800-10. PubMed ID: 2618556
    [Abstract] [Full Text] [Related]

  • 28. Role of microRNA-29b in myelodysplastic syndromes during transformation to overt leukaemia.
    Kirimura S, Kurata M, Nakagawa Y, Onishi I, Abe-Suzuki S, Abe S, Yamamoto K, Kitagawa M.
    Pathology; 2016 Apr; 48(3):233-41. PubMed ID: 27020498
    [Abstract] [Full Text] [Related]

  • 29. Sequential observation of clinical and karyotypic evolution in a patient with myelodysplastic syndrome.
    Xue YQ, Guo Y, Lin BJ, Zhang GR, Lu DW, Wang MH, Gu YZ, Gong JX, Wang LX.
    Chin Med J (Engl); 1989 Sep; 102(9):689-94. PubMed ID: 2517082
    [Abstract] [Full Text] [Related]

  • 30. Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies.
    Mangi MH, Mufti GJ.
    Blood; 1992 Jan 01; 79(1):198-205. PubMed ID: 1370203
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Refractory anemia showing excess of blasts (BAEB) that transformed into acute myelogenous leukemia (AML-M2) with a t (?8;20) chromosomal abnormality].
    Maekawa T, Fujii H, Shizumi Y, Ebisui S, Horishi M, Suyama Y, Miyoshi M, Horiike S.
    Gan No Rinsho; 1988 Dec 01; 34(15):2109-13. PubMed ID: 3230641
    [Abstract] [Full Text] [Related]

  • 33. Are 'dysplastic' and hypogranular megakaryocytes specific markers for myelodysplastic syndrome?
    Wong KF, Chan JK.
    Br J Haematol; 1991 Apr 01; 77(4):509-14. PubMed ID: 2025576
    [Abstract] [Full Text] [Related]

  • 34. [Clinical and cytogenetic study of chromosome 1 abnormality in myelodysplastic syndrome].
    Wang W, Chen Z, Yu M, Wang H, Lou J, Xu H, Hu C, Mu Q, Tong H, Wei J, Zhou X, Jin J.
    Zhonghua Xue Ye Xue Za Zhi; 2015 Oct 01; 36(10):818-23. PubMed ID: 26477758
    [Abstract] [Full Text] [Related]

  • 35. Comparative study of myelodysplastic syndromes and normal bone marrow biopsies with conventional staining and immunocytochemistry.
    Das R, Hayer J, Dey P, Garewal G.
    Anal Quant Cytol Histol; 2005 Jun 01; 27(3):152-6. PubMed ID: 16121636
    [Abstract] [Full Text] [Related]

  • 36. Myelodysplastic syndromes: a study of 101 cases according to the FAB classification.
    Vallespi T, Torrabadella M, Julia A, Irriguible D, Jaen A, Acebedo G, Triginer J.
    Br J Haematol; 1985 Sep 01; 61(1):83-92. PubMed ID: 3863667
    [Abstract] [Full Text] [Related]

  • 37. [Cytogenetic examination of bone marrow cells in stem cell diseases of myelodysplastic syndromes].
    Werner M, Maschek HJ, Kaloutsi V, Buhr T, Kausche F, Delventhal S, Georgii A.
    Verh Dtsch Ges Pathol; 1990 Sep 01; 74():139-43. PubMed ID: 1708572
    [Abstract] [Full Text] [Related]

  • 38. Karyotype in myelodysplastic syndromes: relations to morphology, clinical evolution, and survival.
    Bernasconi P, Alessandrino EP, Boni M, Bonfichi M, Morra E, Lazzarino M, Campagnoli C, Astori C.
    Am J Hematol; 1994 Aug 01; 46(4):270-7. PubMed ID: 8037176
    [Abstract] [Full Text] [Related]

  • 39. Prognostic factors in adult de novo myelodysplastic syndromes treated by intensive chemotherapy.
    Fenaux P, Morel P, Rose C, Lai JL, Jouet JP, Bauters F.
    Br J Haematol; 1991 Apr 01; 77(4):497-501. PubMed ID: 2025575
    [Abstract] [Full Text] [Related]

  • 40. Clinical and morphological features of paediatric myelodysplastic syndromes: a review of 34 cases.
    Polychronopoulou S, Panagiotou JP, Kossiva L, Mavrou A, Anagnostou D, Haidas S.
    Acta Paediatr; 2004 Aug 01; 93(8):1015-23. PubMed ID: 15456186
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.